ANVIGLOBE
LIVE

Serial Number

79346023

Owner

CELLTRION, INC.

Attorney

Max Vern

Filing Date

Jun 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ANVIGLOBE Trademark

Serial Number: 79346023 • Registration: 7256687

ANVIGLOBE is a trademark filed by CELLTRION, INC. on June 9, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Trademark Details

Filing Date

June 9, 2022

Registration Date

January 2, 2024

Published for Opposition

October 17, 2023

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19, pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for the treatment of respiratory diseases, pharmaceutical preparations for the treatment of auto-immune diseases, pharmaceutical preparations for the treatment of immune diseases, pharmaceutical preparations for the treatment of inflammatory diseases, pharmaceutical preparations for use in dermatological diseases, pharmaceutical preparations for the treatment of psoriasis, pharmaceutical preparations for the treatment of arthritis, pharmaceutical preparations for the treatment of spondylitis, pharmaceutical preparations for the treatment of Multiple Sclerosis, pharmaceutical preparations for the treatment of cancer and tumor, pharmaceutical preparations for the treatment of digestive diseases, pharmaceutical preparations for the treatment of metabolic diseases, pharmaceutical preparations for the treatment of endocrine diseases, pharmaceutical preparations for the treatment of genitourinary diseases, pharmaceutical preparations for the treatment of hepatological diseases, pharmaceutical preparations for the treatment of eye diseases, pharmaceutical preparations for the treatment of musculoskeletal disorders, pharmaceutical preparations for the treatment of genetic disorders, pharmaceutical preparations for the treatment of neurological disorders

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 4, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 29, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 2, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Oct 16, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 27, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 5, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 5, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 16, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 8, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 8, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 8, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 8, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 8, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Aug 2, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2022 REPR